U.S. Authorities Charge CANARX Executives in Criminal Case Against Alternative Funding Programs
U.S. federal authorities have charged John Thomas Howard, treasurer and director of the Canadian healthcare company CANARX, with smuggling, conspiracy, and importing misbranded drugs into the United States. His brother, Bob Howard, remains a fugitive facing similar charges. This marks the first criminal case targeting an 'alternative funding program' (AFP), a growing industry that seeks to lower U.S. prescription drug costs by sourcing medications from international markets. The FDA's investigation was bolstered by information regarding ScriptSourcing, a Florida-based competitor. According to court affidavits, federal agents used undercover tactics to investigate these operations after reports of patient harm linked to imported medications. While AFP companies argue that individual importation is legal for personal use, the FDA and Department of Homeland Security maintain that these large-scale commercial schemes violate U.S. import laws and pose significant public health risks.

Topics: alternative funding programs drug importation laws healthcare fraud smuggling charges
Part of the story Federal Authorities Arrest CANARX Officials Over Alleged Illegal Drug Importation Scheme (2 articles)